Deregulation of New Cell Death Mechanisms in Leukemia

Hematological malignancies are among the top five most frequent forms of cancer in developed countries worldwide. Although the new therapeutic approaches have improved the quality and the life expectancy of patients, the high rate of recurrence and drug resistance are the main issues for counteracti...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2024-05, Vol.16 (9), p.1657
Main Authors: Favale, Gregorio, Donnarumma, Federica, Capone, Vincenza, Della Torre, Laura, Beato, Antonio, Carannante, Daniela, Verrilli, Giulia, Nawaz, Asmat, Grimaldi, Francesco, De Simone, Maria Carla, Del Gaudio, Nunzio, Megchelenbrink, Wouter Leonard, Caraglia, Michele, Benedetti, Rosaria, Altucci, Lucia, Carafa, Vincenzo
Format: Article
Language:English
Subjects:
Apoptosis
Autophagy
B cells
Biochemistry
Cancer
Cancer therapies
Cell activation
Cell death
Chemotherapy
Cloning
Development and progression
Drug resistance
Ferroptosis
Health aspects
Homeostasis
Immunotherapy
Kinases
Leukemia
Life span
Lymphoma
Malignancy
Metastasis
Molecular modelling
Morphology
Mutation
Oncology, Experimental
Physiology
Stem cells
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c433t-ffcc004ab74b9f3e0d959796a342f80417880c833006186b10537da691b9735f3
cites cdi_FETCH-LOGICAL-c433t-ffcc004ab74b9f3e0d959796a342f80417880c833006186b10537da691b9735f3
container_end_page
container_issue 9
container_start_page 1657
container_title Cancers
container_volume 16
creator Favale, Gregorio
Donnarumma, Federica
Capone, Vincenza
Della Torre, Laura
Beato, Antonio
Carannante, Daniela
Verrilli, Giulia
Nawaz, Asmat
Grimaldi, Francesco
De Simone, Maria Carla
Del Gaudio, Nunzio
Megchelenbrink, Wouter Leonard
Caraglia, Michele
Benedetti, Rosaria
Altucci, Lucia
Carafa, Vincenzo
description Hematological malignancies are among the top five most frequent forms of cancer in developed countries worldwide. Although the new therapeutic approaches have improved the quality and the life expectancy of patients, the high rate of recurrence and drug resistance are the main issues for counteracting blood disorders. Chemotherapy-resistant leukemic clones activate molecular processes for biological survival, preventing the activation of regulated cell death pathways, leading to cancer progression. In the past decade, leukemia research has predominantly centered around modulating the well-established processes of apoptosis (type I cell death) and autophagy (type II cell death). However, the development of therapy resistance and the adaptive nature of leukemic clones have rendered targeting these cell death pathways ineffective. The identification of novel cell death mechanisms, as categorized by the Nomenclature Committee on Cell Death (NCCD), has provided researchers with new tools to overcome survival mechanisms and activate alternative molecular pathways. This review aims to synthesize information on these recently discovered RCD mechanisms in the major types of leukemia, providing researchers with a comprehensive overview of cell death and its modulation.
doi_str_mv 10.3390/cancers16091657
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3053976676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A793567063</galeid><sourcerecordid>A793567063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-ffcc004ab74b9f3e0d959796a342f80417880c833006186b10537da691b9735f3</originalsourceid><addsrcrecordid>eNptkTtPwzAURi0EolXpzIYisbCktXMTOx6r8pQKLDBHjnvdpuRR7ESIf49Ly6vCHmxZ51x91kfIKaMjAEnHWtUarWOcSsYTcUD6ERVRyLmMD3_de2To3Ir6BcAEF8ekB6kA6rU-SS7R4qIrVVs0ddCY4AHfgimWZXCJql0G96iXqi5c5YKiDmbYvWBVqBNyZFTpcLg7B-T5-uppehvOHm_uppNZqGOANjRGa0pjlYs4lwaQzmUiheQK4sikNGYiTalOASjlLOU5owmIueKS5VJAYmBALrZz17Z57dC1WVU47dOpGpvOZeAFKTgX3KPne-iq6Wzt031SLALJkx9qoUrMito0rVV6MzSbCAkJF5SDp0b_UH7P_ed1U6Mp_PsfYbwVtG2cs2iytS0qZd8zRrNNV9leV94428Xt8grn3_xXM_ABwRaLKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3053123965</pqid></control><display><type>article</type><title>Deregulation of New Cell Death Mechanisms in Leukemia</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Favale, Gregorio ; Donnarumma, Federica ; Capone, Vincenza ; Della Torre, Laura ; Beato, Antonio ; Carannante, Daniela ; Verrilli, Giulia ; Nawaz, Asmat ; Grimaldi, Francesco ; De Simone, Maria Carla ; Del Gaudio, Nunzio ; Megchelenbrink, Wouter Leonard ; Caraglia, Michele ; Benedetti, Rosaria ; Altucci, Lucia ; Carafa, Vincenzo</creator><creatorcontrib>Favale, Gregorio ; Donnarumma, Federica ; Capone, Vincenza ; Della Torre, Laura ; Beato, Antonio ; Carannante, Daniela ; Verrilli, Giulia ; Nawaz, Asmat ; Grimaldi, Francesco ; De Simone, Maria Carla ; Del Gaudio, Nunzio ; Megchelenbrink, Wouter Leonard ; Caraglia, Michele ; Benedetti, Rosaria ; Altucci, Lucia ; Carafa, Vincenzo</creatorcontrib><description>Hematological malignancies are among the top five most frequent forms of cancer in developed countries worldwide. Although the new therapeutic approaches have improved the quality and the life expectancy of patients, the high rate of recurrence and drug resistance are the main issues for counteracting blood disorders. Chemotherapy-resistant leukemic clones activate molecular processes for biological survival, preventing the activation of regulated cell death pathways, leading to cancer progression. In the past decade, leukemia research has predominantly centered around modulating the well-established processes of apoptosis (type I cell death) and autophagy (type II cell death). However, the development of therapy resistance and the adaptive nature of leukemic clones have rendered targeting these cell death pathways ineffective. The identification of novel cell death mechanisms, as categorized by the Nomenclature Committee on Cell Death (NCCD), has provided researchers with new tools to overcome survival mechanisms and activate alternative molecular pathways. This review aims to synthesize information on these recently discovered RCD mechanisms in the major types of leukemia, providing researchers with a comprehensive overview of cell death and its modulation.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers16091657</identifier><identifier>PMID: 38730609</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Apoptosis ; Autophagy ; B cells ; Biochemistry ; Cancer ; Cancer therapies ; Cell activation ; Cell death ; Chemotherapy ; Cloning ; Development and progression ; Drug resistance ; Ferroptosis ; Health aspects ; Homeostasis ; Immunotherapy ; Kinases ; Leukemia ; Life span ; Lymphoma ; Malignancy ; Metastasis ; Molecular modelling ; Morphology ; Mutation ; Oncology, Experimental ; Physiology ; Stem cells ; Tumors</subject><ispartof>Cancers, 2024-05, Vol.16 (9), p.1657</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-ffcc004ab74b9f3e0d959796a342f80417880c833006186b10537da691b9735f3</citedby><cites>FETCH-LOGICAL-c433t-ffcc004ab74b9f3e0d959796a342f80417880c833006186b10537da691b9735f3</cites><orcidid>0009-0005-4991-617X ; 0000-0002-8025-3758 ; 0000-0001-5517-5519 ; 0000-0002-7312-5387 ; 0000-0003-4365-9406 ; 0000-0003-2408-6091</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3053123965/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3053123965?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38730609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Favale, Gregorio</creatorcontrib><creatorcontrib>Donnarumma, Federica</creatorcontrib><creatorcontrib>Capone, Vincenza</creatorcontrib><creatorcontrib>Della Torre, Laura</creatorcontrib><creatorcontrib>Beato, Antonio</creatorcontrib><creatorcontrib>Carannante, Daniela</creatorcontrib><creatorcontrib>Verrilli, Giulia</creatorcontrib><creatorcontrib>Nawaz, Asmat</creatorcontrib><creatorcontrib>Grimaldi, Francesco</creatorcontrib><creatorcontrib>De Simone, Maria Carla</creatorcontrib><creatorcontrib>Del Gaudio, Nunzio</creatorcontrib><creatorcontrib>Megchelenbrink, Wouter Leonard</creatorcontrib><creatorcontrib>Caraglia, Michele</creatorcontrib><creatorcontrib>Benedetti, Rosaria</creatorcontrib><creatorcontrib>Altucci, Lucia</creatorcontrib><creatorcontrib>Carafa, Vincenzo</creatorcontrib><title>Deregulation of New Cell Death Mechanisms in Leukemia</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>Hematological malignancies are among the top five most frequent forms of cancer in developed countries worldwide. Although the new therapeutic approaches have improved the quality and the life expectancy of patients, the high rate of recurrence and drug resistance are the main issues for counteracting blood disorders. Chemotherapy-resistant leukemic clones activate molecular processes for biological survival, preventing the activation of regulated cell death pathways, leading to cancer progression. In the past decade, leukemia research has predominantly centered around modulating the well-established processes of apoptosis (type I cell death) and autophagy (type II cell death). However, the development of therapy resistance and the adaptive nature of leukemic clones have rendered targeting these cell death pathways ineffective. The identification of novel cell death mechanisms, as categorized by the Nomenclature Committee on Cell Death (NCCD), has provided researchers with new tools to overcome survival mechanisms and activate alternative molecular pathways. This review aims to synthesize information on these recently discovered RCD mechanisms in the major types of leukemia, providing researchers with a comprehensive overview of cell death and its modulation.</description><subject>Apoptosis</subject><subject>Autophagy</subject><subject>B cells</subject><subject>Biochemistry</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cell activation</subject><subject>Cell death</subject><subject>Chemotherapy</subject><subject>Cloning</subject><subject>Development and progression</subject><subject>Drug resistance</subject><subject>Ferroptosis</subject><subject>Health aspects</subject><subject>Homeostasis</subject><subject>Immunotherapy</subject><subject>Kinases</subject><subject>Leukemia</subject><subject>Life span</subject><subject>Lymphoma</subject><subject>Malignancy</subject><subject>Metastasis</subject><subject>Molecular modelling</subject><subject>Morphology</subject><subject>Mutation</subject><subject>Oncology, Experimental</subject><subject>Physiology</subject><subject>Stem cells</subject><subject>Tumors</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkTtPwzAURi0EolXpzIYisbCktXMTOx6r8pQKLDBHjnvdpuRR7ESIf49Ly6vCHmxZ51x91kfIKaMjAEnHWtUarWOcSsYTcUD6ERVRyLmMD3_de2To3Ir6BcAEF8ekB6kA6rU-SS7R4qIrVVs0ddCY4AHfgimWZXCJql0G96iXqi5c5YKiDmbYvWBVqBNyZFTpcLg7B-T5-uppehvOHm_uppNZqGOANjRGa0pjlYs4lwaQzmUiheQK4sikNGYiTalOASjlLOU5owmIueKS5VJAYmBALrZz17Z57dC1WVU47dOpGpvOZeAFKTgX3KPne-iq6Wzt031SLALJkx9qoUrMito0rVV6MzSbCAkJF5SDp0b_UH7P_ed1U6Mp_PsfYbwVtG2cs2iytS0qZd8zRrNNV9leV94428Xt8grn3_xXM_ABwRaLKw</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Favale, Gregorio</creator><creator>Donnarumma, Federica</creator><creator>Capone, Vincenza</creator><creator>Della Torre, Laura</creator><creator>Beato, Antonio</creator><creator>Carannante, Daniela</creator><creator>Verrilli, Giulia</creator><creator>Nawaz, Asmat</creator><creator>Grimaldi, Francesco</creator><creator>De Simone, Maria Carla</creator><creator>Del Gaudio, Nunzio</creator><creator>Megchelenbrink, Wouter Leonard</creator><creator>Caraglia, Michele</creator><creator>Benedetti, Rosaria</creator><creator>Altucci, Lucia</creator><creator>Carafa, Vincenzo</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0005-4991-617X</orcidid><orcidid>https://orcid.org/0000-0002-8025-3758</orcidid><orcidid>https://orcid.org/0000-0001-5517-5519</orcidid><orcidid>https://orcid.org/0000-0002-7312-5387</orcidid><orcidid>https://orcid.org/0000-0003-4365-9406</orcidid><orcidid>https://orcid.org/0000-0003-2408-6091</orcidid></search><sort><creationdate>20240501</creationdate><title>Deregulation of New Cell Death Mechanisms in Leukemia</title><author>Favale, Gregorio ; Donnarumma, Federica ; Capone, Vincenza ; Della Torre, Laura ; Beato, Antonio ; Carannante, Daniela ; Verrilli, Giulia ; Nawaz, Asmat ; Grimaldi, Francesco ; De Simone, Maria Carla ; Del Gaudio, Nunzio ; Megchelenbrink, Wouter Leonard ; Caraglia, Michele ; Benedetti, Rosaria ; Altucci, Lucia ; Carafa, Vincenzo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-ffcc004ab74b9f3e0d959796a342f80417880c833006186b10537da691b9735f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Apoptosis</topic><topic>Autophagy</topic><topic>B cells</topic><topic>Biochemistry</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cell activation</topic><topic>Cell death</topic><topic>Chemotherapy</topic><topic>Cloning</topic><topic>Development and progression</topic><topic>Drug resistance</topic><topic>Ferroptosis</topic><topic>Health aspects</topic><topic>Homeostasis</topic><topic>Immunotherapy</topic><topic>Kinases</topic><topic>Leukemia</topic><topic>Life span</topic><topic>Lymphoma</topic><topic>Malignancy</topic><topic>Metastasis</topic><topic>Molecular modelling</topic><topic>Morphology</topic><topic>Mutation</topic><topic>Oncology, Experimental</topic><topic>Physiology</topic><topic>Stem cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Favale, Gregorio</creatorcontrib><creatorcontrib>Donnarumma, Federica</creatorcontrib><creatorcontrib>Capone, Vincenza</creatorcontrib><creatorcontrib>Della Torre, Laura</creatorcontrib><creatorcontrib>Beato, Antonio</creatorcontrib><creatorcontrib>Carannante, Daniela</creatorcontrib><creatorcontrib>Verrilli, Giulia</creatorcontrib><creatorcontrib>Nawaz, Asmat</creatorcontrib><creatorcontrib>Grimaldi, Francesco</creatorcontrib><creatorcontrib>De Simone, Maria Carla</creatorcontrib><creatorcontrib>Del Gaudio, Nunzio</creatorcontrib><creatorcontrib>Megchelenbrink, Wouter Leonard</creatorcontrib><creatorcontrib>Caraglia, Michele</creatorcontrib><creatorcontrib>Benedetti, Rosaria</creatorcontrib><creatorcontrib>Altucci, Lucia</creatorcontrib><creatorcontrib>Carafa, Vincenzo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest research library</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Favale, Gregorio</au><au>Donnarumma, Federica</au><au>Capone, Vincenza</au><au>Della Torre, Laura</au><au>Beato, Antonio</au><au>Carannante, Daniela</au><au>Verrilli, Giulia</au><au>Nawaz, Asmat</au><au>Grimaldi, Francesco</au><au>De Simone, Maria Carla</au><au>Del Gaudio, Nunzio</au><au>Megchelenbrink, Wouter Leonard</au><au>Caraglia, Michele</au><au>Benedetti, Rosaria</au><au>Altucci, Lucia</au><au>Carafa, Vincenzo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deregulation of New Cell Death Mechanisms in Leukemia</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>16</volume><issue>9</issue><spage>1657</spage><pages>1657-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Hematological malignancies are among the top five most frequent forms of cancer in developed countries worldwide. Although the new therapeutic approaches have improved the quality and the life expectancy of patients, the high rate of recurrence and drug resistance are the main issues for counteracting blood disorders. Chemotherapy-resistant leukemic clones activate molecular processes for biological survival, preventing the activation of regulated cell death pathways, leading to cancer progression. In the past decade, leukemia research has predominantly centered around modulating the well-established processes of apoptosis (type I cell death) and autophagy (type II cell death). However, the development of therapy resistance and the adaptive nature of leukemic clones have rendered targeting these cell death pathways ineffective. The identification of novel cell death mechanisms, as categorized by the Nomenclature Committee on Cell Death (NCCD), has provided researchers with new tools to overcome survival mechanisms and activate alternative molecular pathways. This review aims to synthesize information on these recently discovered RCD mechanisms in the major types of leukemia, providing researchers with a comprehensive overview of cell death and its modulation.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38730609</pmid><doi>10.3390/cancers16091657</doi><orcidid>https://orcid.org/0009-0005-4991-617X</orcidid><orcidid>https://orcid.org/0000-0002-8025-3758</orcidid><orcidid>https://orcid.org/0000-0001-5517-5519</orcidid><orcidid>https://orcid.org/0000-0002-7312-5387</orcidid><orcidid>https://orcid.org/0000-0003-4365-9406</orcidid><orcidid>https://orcid.org/0000-0003-2408-6091</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2024-05, Vol.16 (9), p.1657
issn 2072-6694
2072-6694
language eng
recordid cdi_proquest_miscellaneous_3053976676
source PubMed Central Free; Publicly Available Content Database
subjects Apoptosis
Autophagy
B cells
Biochemistry
Cancer
Cancer therapies
Cell activation
Cell death
Chemotherapy
Cloning
Development and progression
Drug resistance
Ferroptosis
Health aspects
Homeostasis
Immunotherapy
Kinases
Leukemia
Life span
Lymphoma
Malignancy
Metastasis
Molecular modelling
Morphology
Mutation
Oncology, Experimental
Physiology
Stem cells
Tumors
title Deregulation of New Cell Death Mechanisms in Leukemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A41%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deregulation%20of%20New%20Cell%20Death%20Mechanisms%20in%20Leukemia&rft.jtitle=Cancers&rft.au=Favale,%20Gregorio&rft.date=2024-05-01&rft.volume=16&rft.issue=9&rft.spage=1657&rft.pages=1657-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers16091657&rft_dat=%3Cgale_proqu%3EA793567063%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-ffcc004ab74b9f3e0d959796a342f80417880c833006186b10537da691b9735f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3053123965&rft_id=info:pmid/38730609&rft_galeid=A793567063&rfr_iscdi=true